| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $74.3M | — | -0.0% |
| Cost of Revenue | $37.8M | — | +0.5% |
| Gross Profit | $36.5M | — | -0.6% |
| R&D Expense | $28.7M | — | +13.5% |
| SG&A Expense | $12.6M | — | +1.7% |
| Operating Income | -$15.2M | — | -58.5% |
| Interest Expense | $773K | — | -36.8% |
| Pre-tax Income | -$25.2M | — | -188.7% |
| Income Tax | $48K | — | +117.1% |
| Net Income | -$25.3M | — | -198.9% |
| EPS (Basic) | -$0.83 | — | -176.7% |
| EPS (Diluted) | -$0.83 | — | -176.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $32.3M | -33.0% | -47.3% |
| Short-term Investments | $99.5M | -21.7% | +14.9% |
| Accounts Receivable | $72.4M | +2.2% | +26.7% |
| Inventory | $86.3M | +1.6% | -12.4% |
| Current Assets | $299.0M | -11.8% | -3.1% |
| Total Assets | $502.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $4.0M | — | +135.7% |
| Capital Expenditures | $1.7M | — | -6.2% |
| Investing Cash Flow | $25.7M | — | +21.2% |
| Financing Cash Flow | -$45.6M | — | -1000.7% |
| Free Cash Flow | $2.2M | — | +117.2% |
| +4.7% |
| Current Liabilities | $32.5M | -74.3% | +15.4% |
| Long-term Debt | $241.5M | -14.0% | -14.9% |
| Total Liabilities | $298.6M | -11.1% | -6.5% |
| Stockholders' Equity | $203.9M | -2.5% | +27.0% |